Prognostic factors in lymph node-positive prostate cancer

Abstract
No abstract available
Funding Information
  • Dana-Farber/Harvard Cancer Center
  • U.S. Department of Defense (PC030214)
  • National Cancer Institute (P50CA90381, R01AG21404)